Skip to search formSkip to main contentSkip to account menu

MK 826

Known as: MK-826 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Abstractβ-Lactam antibiotics represent the most commonly prescribed antibacterial agents. New β-lactams have been introduced… 
Review
2002
Review
2002
  • B. Cunha
  • Drugs of today
  • 2002
  • Corpus ID: 10601017
Ertapenem sodium (trade name Invanz, also designated as MK-0826, MK-826 and L-749345), manufactured by Merck & Co., Inc. is a… 
Review
2001
Review
2001
Beta-lactam antibiotics represent the most commonly prescribed antibacterial agents. New beta-lactams have been introduced… 
Review
2000
Review
2000
During the last few decades, several carbapenems have been developed. The major characteristic of the newer drugs, such as MK-826… 
2000
2000
ABSTRACT The activity of MK-826 was compared to the activities of cefoxitin, ceftriaxone, imipenem, and meropenem against 363… 
1999
1999
After intravenous administration of MK-826, a new carbapenem antibiotic, the compound exhibited nonlinear pharmacokinetics in… 
Highly Cited
1998
Highly Cited
1998
ABSTRACT MK-826 (formerly L-749,345), is a potent 1-β-methyl carbapenem with a long half-life and broad spectrum of activity…